Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis

Perakakis, Nikolaos; Bornstein, Stefan R.; Birkenfeld, Andreas L.; Linkermann, Andreas; Demir, Muenevver; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M.; Kolkhof, Peter; Lawatscheck, Robert; Scott, Charlie; Bakris, George L.

dc.contributor.author	Birkenfeld, Andreas L.
dc.date.accessioned	2024-09-03T06:03:21Z
dc.date.available	2024-09-03T06:03:21Z
dc.date.issued	2024
dc.identifier.issn	1462-8902
dc.identifier.uri	http://hdl.handle.net/10900/157123
dc.language.iso	en	de_DE
dc.publisher	Hoboken : Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.15305	de_DE
dc.subject.ddc	610	de_DE
dc.title	Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_01407
utue.publikation.seiten	191-200	de_DE
utue.personen.roh	Perakakis, Nikolaos
utue.personen.roh	Bornstein, Stefan R.
utue.personen.roh	Birkenfeld, Andreas L.
utue.personen.roh	Linkermann, Andreas
utue.personen.roh	Demir, Muenevver
utue.personen.roh	Anker, Stefan D.
utue.personen.roh	Filippatos, Gerasimos
utue.personen.roh	Pitt, Bertram
utue.personen.roh	Rossing, Peter
utue.personen.roh	Ruilope, Luis M.
utue.personen.roh	Kolkhof, Peter
utue.personen.roh	Lawatscheck, Robert
utue.personen.roh	Scott, Charlie
utue.personen.roh	Bakris, George L.
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	26	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE